These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12476899)

  • 21. Brain histamine H1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine.
    Hiraoka K; Tashiro M; Grobosch T; Maurer M; Oda K; Toyohara J; Ishii K; Ishiwata K; Yanai K
    Expert Opin Drug Saf; 2015 Feb; 14(2):199-206. PubMed ID: 25466429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticholinergic activity of antihistamines.
    Yanai K
    Clin Neurophysiol; 2012 Apr; 123(4):633-4. PubMed ID: 21963322
    [No Abstract]   [Full Text] [Related]  

  • 23. Histamine H1 antagonists and histamine release from human lung in vitro [proceedings].
    Church MK; Gradidge CF
    Br J Pharmacol; 1979 May; 66(1):68P. PubMed ID: 88242
    [No Abstract]   [Full Text] [Related]  

  • 24. [Oral second generation antihistamines in allergic rhinitis].
    Riechelmann H
    Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of H1- and H2-receptor antagonists on the hemodynamic changes induced by the intravenous administration of ketamine in sevoflurane-anesthetized cats.
    Costa-Farré C; García F; Andaluz A; Torres R; de Mora F
    Inflamm Res; 2005 Jun; 54(6):256-60. PubMed ID: 15973509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. H1- and H2-receptor antagonists prevent histamine release in allergic patients after the administration of midazolam-ketamine. A randomized controlled study.
    Kimura K; Adachi M; Kubo K
    Inflamm Res; 1999 Mar; 48(3):128-32. PubMed ID: 10219654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
    Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
    J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of the histamine receptors in the inhibition of histamine release--blocking examination with H1 and H2 antagonists in the leukocytes of cedar pollinosis patients].
    Baba K; Goto H; Furuuchi I
    Nihon Jibiinkoka Gakkai Kaiho; 1986 Nov; 89(11):1703-8. PubMed ID: 2434636
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
    Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacological study of pipratecol (JP 711) and of a pharmaceutical combination raubasine-JP 711].
    Laubie M; Le Douarec JC
    Arzneimittelforschung; 1969 Nov; 19(11):1820-6. PubMed ID: 4391788
    [No Abstract]   [Full Text] [Related]  

  • 31. Some cardiovascular actions of cyclizine, chlorcyclizine and homchlorcyclizine.
    Madan BR; Pendse VK
    Indian J Physiol Pharmacol; 1969 Jul; 13(3):113-21. PubMed ID: 4391331
    [No Abstract]   [Full Text] [Related]  

  • 32. A role for the central histaminergic system in the leptin-mediated increase in cardiovascular dynamics.
    Rao SP; Dunbar JC
    Brain Res Bull; 2005 Jan; 64(5):425-32. PubMed ID: 15607830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of H1 and H2 histamine blockers on hemodynamic changes during high dose morphine anesthesia].
    Noguchi T; Hayano Y; Miyamoto M; Yamamori S; Oda S; Taniguchi K; Honda Y; Honda N
    Masui; 1984 Jun; 33(6):631-4. PubMed ID: 6148430
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of histamine in the cardiovascular effects of atracurium.
    Adt M; Baumert JH; Reimann HJ
    Br J Anaesth; 1992 Feb; 68(2):155-60. PubMed ID: 1347230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined H1 and H2 receptor blockade attenuates the cardiovascular effects of high-dose atracurium for rapid sequence endotracheal intubation.
    Hosking MP; Lennon RL; Gronert GA
    Anesth Analg; 1988 Nov; 67(11):1089-92. PubMed ID: 2461127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiology and pharmacology of cardiac histamine.
    Mannaioni PF
    Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:64-7. PubMed ID: 4115299
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro and in vivo studies of the non-sedating antihistamine epinastine.
    Fügner A; Bechtel WD; Kuhn FJ; Mierau J
    Arzneimittelforschung; 1988 Oct; 38(10):1446-53. PubMed ID: 2461715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The immunotropic activity of H1 antihistaminic preparations].
    Alekhin EK; Krasilova IL
    Eksp Klin Farmakol; 1998; 61(2):79-86. PubMed ID: 9621183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.
    Naclerio RM; Kagey-Sobotka A; Lichtenstein LM; Freidhoff L; Proud D
    Am Rev Respir Dis; 1990 Jul; 142(1):167-71. PubMed ID: 1695070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of the local antihistamine effect of dermatological preparations.
    Guillerm R
    Arzneimittelforschung; 1974 Sep; 24(9):1350-2. PubMed ID: 4139960
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.